HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women

Anja K. Wege(University of Regensburg), Gero Brockhoff(University of Regensburg)

Breast Cancer Research

November 20, 2018

10.1186/s13058-018-1072-1

Cited by 19

Related Papers

Humanized tumor mice—A new model to study and manipulate the immune response in advanced cancer therapy

|International Journal of Cancer|2011|105

Loss of PTEN is associated with elevated EGFR and HER2 expression and worse prognosis in salivary gland cancer

|British Journal of Cancer|2012|59

Modular anti‐EGFR and anti‐Her2 targeting of SK‐BR‐3 and BT474 breast cancer cell lines in the presence of ErbB receptor‐specific growth factors

|Cytometry Part A|2011|35

Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion

|Cancers|2023|19

Multichromatic phenotyping of HER receptor coexpression in breast tumor tissue samples using flow cytometry—Possibilities and limitations

|Cytometry Part A|2010|11